BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bio-Rad Laboratories, Inc. (BIO) Release: New Digital PCR Technology Counts Target DNA Molecules


12/7/2011 11:24:27 AM

Hercules, CA — December 5, 2011 — A new, high-throughput digital PCR technology called Droplet Digital PCR™ (ddPCR™) was shown to provide an absolute measure of nucleic acids in a sample in the November 15 issue of Analytical Chemistry.

According to Ben Hindson, Ph.D., the paper's first author and a Bio-Rad Laboratories, Inc. chemist, ddPCR overcomes the high costs, limited throughput, and complicated workflows that hampered adoption of earlier commercial digital PCR systems.

Bio-Rad offers the ddPCR technology with its QX100™ Droplet Digital PCR system.

"The QX100 Droplet Digital PCR system's ability to count nucleic acids molecule by molecule will allow researchers to study biological systems with unprecedented precision," said Hindson. "We anticipate this will enable researchers to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics."

Rise of Third-Generation PCR

First generation PCR users obtain qualitative results by end-point analysis using gel electrophoresis. Real-time PCR led to a second generation that enables relative quantification by monitoring amplification using a fluorescence chemistry added to the reaction. Quantification requires the use of a standard curve or reference gene when performing gene expression analysis. Typically, only two-fold differences in starting concentration can be observed.

Droplet Digital PCR is third-generation PCR, which enables precise measurements of DNA concentration, to provide absolute quantitation as a digital readout. The droplet technology enables digital PCR in a low-cost and practical format.

The QX100 Droplet Digital PCR system partitions the sample into ~20,000 individual droplets wherein PCR is carried out. These droplets are streamed in single file past a detector to count the negative and positive reactions. This digitization of PCR reactions allows a more reliable and sensitive measurement of nucleic acid amounts.

"The massive partitioning afforded by our Droplet Digital PCR provides orders of magnitude more precision and sensitivity than other technologies," said Hindson.

Counting Copies, Detecting Rare Alleles, and Quantifying Plasma DNA

The Analytical Chemistry paper demonstrates the utility of the QX100 Droplet Digital PCR system in three application areas of increasing interest to researchers: copy number variation (CNV) determination, rare allele detection, and plasma DNA quantification.

For CNVs, the large number of droplet partitions provides sufficient precision to accurately measure copy number states. Using the QX100 Droplet Digital PCR system to screen HapMap samples for CNVs, copy number states were shown to be completely resolved.

For the detection of rare alleles, partitioning the target mutant DNA away from highly homologous wildtype DNA increases sensitivity. With the QX100 Droplet Digital PCR system, researchers detected a 0.001% mutant fraction of BRAF V600E, which is 1,000 times more sensitive than real-time PCR.

Finally, Droplet Digital PCR enabled accurate quantitation of highly fragmented cell-free DNA in maternal plasma, an important sample matrix for emerging noninvasive tests.

To read the Analytical Chemistry paper on ddPCR, visit http://pubs.acs.org/doi/abs/10.1021/ac202028g. For more information on the QX100 Droplet Digital PCR system, visit http://bit.ly/QX100.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, and major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs more than 6,800 people globally and had revenues exceeding $1.9 billion in 2010. For more information, please visit http://www.biorad.com.

For more information contact:

Richard Kurtz

Bio-Rad

800-876-3425 x 5638

Richard_Kurtz@bio-rad.com

Ken Li

Chempetitive Group

312-997-2436

kli@chempetitive.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES